Testimonials
Here is what a few of our corporate partners are saying about the New York Academy of Sciences…
"A unique resource"
“Throughout my career in the drug industry, I have worked at companies that were strong supporters and corporate members of the New York Academy of Sciences. As a discovery scientist, I have always been encouraged to participate in Academy meetings, particularly the Biochemical Pharmacology Discussion Group. Thanks to memberships provided through our corporate membership, my colleagues and I are able to attend BPDG meetings frequently.
“The 1/2 to 1-day meetings are a very efficient way to get up to speed on new topics, something essential to discovery scientists who are often asked to move to new projects on very short notice. The Academy also provides an opportunity for us to propose and organize meetings on topics of particular interest to pharmaceutical scientists. We are able to invite the top scientists in a particular field, from both academia and industry, to a neutral setting where we discuss science freely. We bring back new ideas that help us to move projects, and at the same time, we help to build our company's reputation with the scientific community. In the past few years, the Academy has enhanced the experience by adding new discussion groups of interest to the drug industry on topics such as predictive toxicology.
“Corporate memberships provide the funding for these groups, and they also make it possible for the Academy to produce detailed Web-based meeting reports called eBriefings. Now even my corporate colleagues in Europe and Japan can benefit from the meetings we sponsor in New York City. The New York Academy is a unique resource that helps drug discovery and development scientists keep up with the newest scientific developments.”
Carolyn J. Foster, PhD
Senior Associate Director, Technology Assessment
Boehringer Ingelheim Pharmaceuticals, Inc.
"Access to some of the world's finest scientific talent"
“Wyeth Discovery Research has partnered with the New York Academy of Science (NYAS) for more than four years. During this time we have realized a number of benefits from this relationship including participation in and speaking opportunities at NYAS-hosted events; as well as access to NYAS's extensive network of New York, national, and international based scientists and partner organizations.
“In addition, membership to the NYAS has provided access to some of the world's finest scientific talent and has therefore resulted in a number of recruitment opportunities. Almost 1/4 of our internal scientists are members of the Academy and all have utilized their memberships to expand their scientific knowledge through attendance at NYAS meetings/seminars or by accessing the post-event e-briefings.
“In addition to the scientific networking, knowledge sharing and recruitment benefits of our partnership, the added benefit of access to the academy's state-of-the-art facilities in Manhattan is a considerable advantage and has enabled us to host, and consider hosting, events ranging from 10-200 people. We truly value our partnership with the NYAS and have enjoyed a close working relationship with many of the team at the Academy who are always available and willing to assist us and suggest ways for maximizing the success and benefits of our membership.”
Frank S. Walsh, PhD
Executive Vice President, Discovery Research
Wyeth Pharmaceuticals
A shared mission
“Merck has provided support to the New York Academy of Sciences since 2005, including funding for Scientists Without Borders. Merck's mission as a global research-based pharmaceutical company aligns well with the Academy's mission of employing scientific solutions to overcome the major challenges facing society. Like the Academy, we're committed to pursuing creative solutions to address pressing global health and development issues.
“It has been very exciting for us to see Scientists Without Borders—which was a mere concept just a few years ago—evolve into a robust and powerful tool for sharing information and best practices, fostering collaboration and ultimately forging an integrated approach to address complex challenges in the developing world. The New York Academy of Sciences has developed an innovative tool to allow scientific networking with unprecedented speed and reach. As a result of the Academy’s hard work and dedication to this initiative, the best and the brightest will be able to collaborate on projects enabling the global community to work toward the achievement of the Millennium Development Goals more efficiently and effectively. Merck is proud to be a partner with NYAS in this important initiative.”
Brenda D. Colatrella
Executive Director, Office of Corporate Responsibility & Global Policy Support
Merck & Co., Inc.
Contact Us
For more information about corporate membership, please contact:
Monica Kurpiewski
Director, Business Development
212.298.8637
mkurpiewski@nyas.org